Innocan Pharma’s CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

CANNANNEW REPORT

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – May 14, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)… Read More…..

Excerpt only …
READ MORE BELOW
Source : Innocan Pharma’s CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.